NasdaqCM - Delayed Quote USD

Oramed Pharmaceuticals Inc. (ORMP)

2.4600 +0.1600 (+6.96%)
At close: April 26 at 4:00 PM EDT
2.4800 +0.02 (+0.81%)
After hours: April 26 at 5:38 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for ORMP

Recent News: ORMP

View More
Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation

Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation
GlobeNewswire last month
Oramed Pharmaceuticals Full Year 2023 Earnings: Beats Expectations

Oramed Pharmaceuticals Full Year 2023 Earnings: Beats Expectations
Simply Wall St. last month
Oramed Letter to Shareholders

Oramed Letter to Shareholders
PR Newswire 2 months ago

ORMP: Multiple Potential Applications for Proprietary Oral Protein Delivery Platform
Zacks Small Cap Research 3 months ago
Oramed Pharmaceuticals (NASDAQ:ORMP) investors are sitting on a loss of 63% if they invested a year ago

Oramed Pharmaceuticals (NASDAQ:ORMP) investors are sitting on a loss of 63% if they invested a year ago
Simply Wall St. 6 months ago
ORMP: Distribution Deals, JVs in Anticipation of Commercializing ORMD-0801

ORMP: Distribution Deals, JVs in Anticipation of Commercializing ORMD-0801
Zacks Small Cap Research 6 months ago
Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company

Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company
PR Newswire 7 months ago
Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company

Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company
PR Newswire 7 months ago
Scilex Holding Company Announces the Consummation of the Previously Announced Purchase of all of the Scilex Common Shares, Preferred Shares and Warrants Owned by Sorrento Therapeutics, Inc.

Scilex Holding Company Announces the Consummation of the Previously Announced Purchase of all of the Scilex Common Shares, Preferred Shares and Warrants Owned by Sorrento Therapeutics, Inc.
GlobeNewswire 7 months ago
Scilex Holding Company Enters into Non-Binding Term Sheets for the Purchase of all of the Scilex Common Shares, Preferred Shares, and Warrants Currently Owned by Sorrento Therapeutics, Inc. and is Declared the New Successful Bidder

Scilex Holding Company Enters into Non-Binding Term Sheets for the Purchase of all of the Scilex Common Shares, Preferred Shares, and Warrants Currently Owned by Sorrento Therapeutics, Inc. and is Declared the New Successful Bidder
GlobeNewswire 7 months ago
Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globally

Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globally
PR Newswire 8 months ago
Oramed to Present at the 83rd American Diabetes Association Conference

Oramed to Present at the 83rd American Diabetes Association Conference
PR Newswire 10 months ago
View More

Related Tickers

ENLV Enlivex Therapeutics Ltd.
1.4400
-0.69%
 
EVGN Evogene Ltd.
0.6251
-4.91%
 
BLRX BioLineRx Ltd.
0.6116
+6.31%
 
CGEN Compugen Ltd.
1.9200
+1.05%
 
CANF Can-Fite BioPharma Ltd.
1.9800
+3.13%
 
EVGN.TA Evogene Ltd.
256.20
-1.16%
 
PLUR Pluri Inc.
5.36
+2.23%
 
BONS.TA Bonus BioGroup Ltd.
16.90
0.00%
 
IFRX InflaRx N.V.
1.3300
-4.32%
 
CALC CalciMedica, Inc.
5.45
-0.18%